FDA-cleared profile

Follicle Clarity

Cycle Clarity · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Aid to interpreting clinicians for calculating the number and size of ovarian follicles in a transvaginal ultrasound volume sweep of the ovaries.

Clinical role
Measurement and quantification aid during transvaginal ovarian ultrasound review, with clinician ability to verify images and add or delete measurements.
Images and patients
Ultrasound · Ovaries; ovarian follicles
Key limitation
Keep in mind: The packet establishes follicle count and size quantification against manual and SonoAVC comparisons but does not establish a diagnostic claim, a numeric sensitivity/specificity endpoint, or a particular care setting or current interface version.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Aid to interpreting clinicians for calculating the number and size of ovarian follicles in a transvaginal ultrasound volume sweep of the ovaries.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Ovaries; ovarian follicles Input: DICOM transvaginal ultrasound volume-sweep images of the ovaries from compatible ultrasound systems.
  • Who uses it?Intended users: Interpreting clinicians.
  • What does the software produce?Output: Automatically calculated ovarian follicle count and size in graphical and tabular displays, with the received images and clinician measurements available for review and adjustment.
  • What is its most important limitation?Key limitation: The packet establishes follicle count and size quantification against manual and SonoAVC comparisons but does not establish a diagnostic claim, a numeric sensitivity/specificity endpoint, or a particular care setting or current interface version.

Clinical takeaway. Clinical role: Aid to interpreting clinicians for calculating the number and size of ovarian follicles in a transvaginal ultrasound volume sweep of the ovaries.

Evidence takeaway. Evidence from the reviewed source record: Non-clinical validation included a phantom trial and two ovarian validation trials covering ovaries with three or fewer and ten or more follicles; one-to-one tracking and measurement accuracy was within the margin of error for human measurements. Prospective clinical validation compared follicle size and count with manual ultrasonographer and SonoAVC measurements and met the predetermined endpoints. The packet reports accuracy, precision, and agreement objectives but no numeric sensitivity or specificity.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Aid to interpreting clinicians for calculating the number and size of ovarian follicles in a transvaginal ultrasound volume sweep of the ovaries.
  • Exact FDA submission
  • Checked 2026-09-09
Workflow role
Measurement and quantification aid during transvaginal ovarian ultrasound review, with clinician ability to verify images and add or delete measurements.
  • Exact FDA submission
  • Checked 2026-09-09
Required input
DICOM transvaginal ultrasound volume-sweep images of the ovaries from compatible ultrasound systems.
  • Exact FDA submission
  • Checked 2026-09-09
Output and clinician action
Automatically calculated ovarian follicle count and size in graphical and tabular displays, with the received images and clinician measurements available for review and adjustment.
  • Exact FDA submission
  • Checked 2026-09-09
Intended users
Interpreting clinicians.
  • Exact FDA submission
  • Checked 2026-09-09
Limitations
The packet establishes follicle count and size quantification against manual and SonoAVC comparisons but does not establish a diagnostic claim, a numeric sensitivity/specificity endpoint, or a particular care setting or current interface version.
  • Exact FDA submission
  • Checked 2026-09-09
Evidence summary
Non-clinical validation included a phantom trial and two ovarian validation trials covering ovaries with three or fewer and ten or more follicles; one-to-one tracking and measurement accuracy was within the margin of error for human measurements. Prospective clinical validation compared follicle size and count with manual ultrasonographer and SonoAVC measurements and met the predetermined endpoints. The packet reports accuracy, precision, and agreement objectives but no numeric sensitivity or specificity.
  • Exact FDA submission
  • Checked 2026-09-09

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Non-clinical validation included a phantom trial and two ovarian validation trials covering ovaries with three or fewer and ten or more follicles; one-to-one tracking and measurement accuracy was within the margin of error for human measurements. Prospective clinical validation compared follicle size and count with manual ultrasonographer and SonoAVC measurements and met the predetermined endpoints. The packet reports accuracy, precision, and agreement objectives but no numeric sensitivity or specificity.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Follicle Clarity Software regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPopulation described in the exact-submission ACR model card
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K212012
  • IndependenceIndependence not established

K212012

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K212012. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM transvaginal ultrasound volume-sweep images of the ovaries from compatible ultrasound systems.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-09 · FDA K212012: Follicle Clarity

  2. Routing

    Source context, not route validation: The application is cloud-based and uses DICOM patient clinical data from compatible ultrasound systems; the packet does not establish specific PACS, RIS, EHR, or transfer interfaces.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-09 · FDA K212012: Follicle Clarity

  3. AI processing

    Source context, not route validation: The exact FDA package describes Follicle Clarity as a cloud-based software application package (software as a medical device), without detailing the hosting environment. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Follicle Clarity is a cloud-based software application package (software as a medical device, SaMD).". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K212012: Follicle Clarity

  4. Returned objects

    Source context, not route validation: Automatically calculated ovarian follicle count and size in graphical and tabular displays, with the received images and clinician measurements available for review and adjustment.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-09 · FDA K212012: Follicle Clarity

  5. Viewer/worklist/report

    Unresolved route: Automatically calculated ovarian follicle count and size in graphical and tabular displays, with the received images and clinician measurements available for review and adjustment.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-09 · FDA K212012: Follicle Clarity

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Follicle Clarity as a cloud-based software application package (software as a medical device), without detailing the hosting environment. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Follicle Clarity is a cloud-based software application package (software as a medical device, SaMD).". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The application is cloud-based and uses DICOM patient clinical data from compatible ultrasound systems; the packet does not establish specific PACS, RIS, EHR, or transfer interfaces.
  • Exact FDA submission
  • Checked 2026-09-09
Security
Cycle Clarity's trust center reports HIPAA and SOC 2 Type 2 'Compliant' status and publishes a controls overview including MFA for critical services, access granting and revocation processes, account inventory, dormant-account disabling, regular access reviews, and password management.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statements, not attestations. Audit reports are request-gated and were not read; the trust center names Cycle Clarity generally and does not scope the claims to Follicle Clarity or any specific release; exact-release scope is not established.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Follicle Clarity; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K212012
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Anatomy
Ovaries; ovarian follicles
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-01-19
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Care setting: Not publicly available - checked 2026-11-14 - Exact FDA submission

    The exact FDA decision document was reviewed on 2026-11-14 and does not state a care setting or patient population for the subject device. Confirm intended sites and patients with the vendor and local policy.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K212012 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K212012: Follicle Clarity

    U.S. Food and Drug Administration - Published 2022-01-19 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Follicle Clarity Software model card (K212012)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K212012

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

  8. Cycle Clarity: Trust Center

    Cycle Clarity - Accessed 2026-10-27

    Scope: security

Research history

  1. K212012 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29
FDA-cleared K260190

ARTHUR

ROPCA ApS

Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.

Modality
Ultrasound
Anatomy
Hand/Wrist
Decision
2026-06-18
FDA-cleared K260844

ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: ACUSON Sequoia, Select, Origin, and Origin ICE diagnostic ultrasound systems acquire and display the labeled fetal, abdominal, pediatric, neonatal, cephalic, small-part, obstetric, cardiac, transesophageal, intracardiac, vascular, and musculoskeletal examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; transesophageal and intracardiac applications
Decision
2026-06-16
FDA-cleared K260300

WatchMate Software

Anumana, Inc.

Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.

Modality
Ultrasound
Anatomy
Heart and left atrial appendage
Decision
2026-06-15

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history